{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01013064: Phase 1 Interventional Completed Healthy
(2009)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02938299: Phase 3 Interventional Recruiting Malignant Melanoma
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00611208: Phase 2 Interventional Completed T-cell Lymphomas
(2008)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03089645: Phase 1 Interventional Completed Advanced Solid Tumors
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02520791: Phase 1 Interventional Active, not recruiting Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04219254: Phase 1/Phase 2 Interventional Recruiting Solid Tumor, Adult
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02748642: Phase 1 Interventional Completed Mild Atopic Asthma
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01004822: Phase 1 Interventional Terminated Advanced Solid Tumors
(2010)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00606645: Phase 1 Interventional Completed Hodgkin Lymphoma
(2007)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03955666: Phase 1 Interventional Completed Safety
(2019)
Source URL:
Class:
CONCEPT